A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells
Therapeutic monoclonal antibodies (mAb) targeting the immune checkpoint inhibitor
programmed cell death protein 1 (PD-1) have achieved considerable clinical success in anti …
programmed cell death protein 1 (PD-1) have achieved considerable clinical success in anti …